Found: 1
Select item for more details and to access through your institution.
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV).
- Published in:
- eLife, 2023, p. 1, doi. 10.7554/eLife.83201
- By:
- Publication type:
- Article